Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205283 · ClinicalTrials.gov registry record · NA
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00205283 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants.
The verdict
NCT00205283, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of prospective drug level monitoring and dose-adjustment of nelfinavir (NFV) on the clinical and virologic outcomes in a group of HIV-infected patients who have achieved virologic success while receiving a nelfinavir containing highly active antiretroviral therapy (HAART) regimen.
Interventions
- DRUG Nelfinavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205283
The ClinicalTrials.gov registry entry for NCT00205283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nelfinavir is the first listed.
NCT00205283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205283 about?
NCT00205283 is a clinical study titled "Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection". The purpose of this study is to assess the impact of prospective drug level monitoring and dose-adjustment of nelfinavir (NFV) on the clinical and virologic outcomes in a group of HIV-infected patients who have achieved virologic success while receiving a nelfinavir containing highly active antiretr...
What is the current status of trial NCT00205283?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2003-08. Estimated completion is 2005-08-01.
What interventions are being tested in trial NCT00205283?
The interventions under investigation include: Nelfinavir (DRUG).
Who is sponsoring clinical trial NCT00205283?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.